CFD
PRCT icon

Creative Financial Designs’s Procept Biorobotics PRCT Stock Holding History

Creative Financial Designs’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361 Hold
16
– – ﹤0.01% 2165
2026
Q1 		$400 Hold
16
– – ﹤0.01% 2021
2025
Q4 		$503 Hold
16
– – ﹤0.01% 1907
2025
Q3 		$571 Hold
16
– – ﹤0.01% 1906
2025
Q2 		$922 Hold
16
– – ﹤0.01% 1790
2025
Q1 		$932 Buy
+16
New +$1.09K ﹤0.01% 1795

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Creative Financial Designs's PRCT Position: Q2 2026 in Review

Creative Financial Designs held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 16 shares worth $361. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Creative Financial Designs first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $932 in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Creative Financial Designs held 16 shares of Procept Biorobotics worth $361 as of Q2 2026.
  • Creative Financial Designs left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2165 holding.
  • Creative Financial Designs first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Creative Financial Designs's Procept Biorobotics position peaked at $932 in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.